EIF3E and breast carcinoma: In search of the underlying mechanism, we found that eIF3e deficiency causes reduced PARP1 expression and mTORC1 hyperactivation that drive breast cancer cells into senescence and secretion of inflammatory factors, providing potential novel cancer therapeutic opportunities.